Status:
UNKNOWN
The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis
Lead Sponsor:
Phoilex Ltd.
Collaborating Sponsors:
Phoenix Medical Spa X Peak Human
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to learn about the potential therapeutic effects of topical CBD products produced by Phoilex Ltd., specifically the Releaf Gel, in those diagnosed with atopic d...
Eligibility Criteria
Inclusion
- Specifically, patients would be recruited based on the following inclusion criteria must be over 18 years old and must be diagnosed with moderate-to-severe eczema.
Exclusion
- Exclusion criteria would include not currently using any steroids or biologics, not currently using any other topical products, not pregnant, not breast feeding, nor have any allergies to any ingredients listed within the formula of the Releaf gel. A negative pregnancy test will need to be confirmed prior to patient receiving Phoilex Releaf Gel. Lastly, participants who have been diagnosed with anxiety or depression with a classification of greater than mild anxiety or mild depression will be excluded. As such, screening for possible candidates for the clinical trial will include questions and a brief assessment on participants mental health by study doctor/physician.
Key Trial Info
Start Date :
July 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06022874
Start Date
July 15 2023
End Date
October 30 2023
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix Medical Spa X Peak Human
Brampton, Ontario, Canada, L6W 3E1